PharmGen Science, Inc. (KRX:004720)

Market Cap	91.49B +29.2%
Revenue (ttm)	171.66B -0.0%
Net Income	117.75M -98.2%
EPS	6.50 -98.1%
Shares Out	21.91M
PE Ratio	776.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	531,976
Average Volume	92,070
Open	3,965.00
Previous Close	3,960.00
Day's Range	3,960.00 - 4,290.00
52-Week Range	3,410.00 - 5,490.00
Beta	0.31
RSI	69.01
Earnings Date	Apr 3, 2026

About PharmGen Science

PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1957 and is headquartered in Hwaseong-si, South Korea.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1957
• Employees: 226
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 004720

Financial Performance

In 2024, PharmGen Science's revenue was 171.29 billion, an increase of 2.70% compared to the previous year's 166.78 billion. Earnings were 2.79 billion, a decrease of -54.17%.